Etoposide in Treating Patients With Relapsed Non-Hodgkin’s Lymphoma
Study Information
Alliance Study ID: CALGB-9650
NCT Study ID (ClinicalTrials.gov): NCT00002880
Alliance Committee: Lymphoma
Disease or Cancer Type: Lymphoma
Alliance Study Chair: Nancy Bartlett, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of etoposide in treating patients with relapsed non-Hodgkin’s lymphoma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information